Solesence, Inc. Common Stock
NASDAQ:SLSNHousehold & Personal Products
+$0.05 today
- Market cap
- $115.86M
- Beta
- 1.24
- P/E (TTM)
- 99.5
- EPS (TTM)
- $0.01
Volume 0.30M
Average 0.04M
SLSN Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
Solesence, Inc. Common StockNASDAQ: SLSN
Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Investing cash flow turns negative
Q1 FY2026 investing cash flow was -$528K, compared with $133K a year earlier. Trailing-twelve-month investing cash flow was -$2.8M. Over 3 fiscal years it compounded at -8.8% a year.
Context
- Investing cash flow amounted to 3.5% of revenue in FY2025, down 5.3 pp from a year earlier.
- Investing cash flow grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly investing cash flow holds near -$528K or moves back toward the trailing-twelve-month quarterly average of -$701K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (2.14M) USD
- Year-over-year change
- +53.0%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (2.14M) | +53.0% |
| FY2024 | 2024-12-31 | (4.56M) | -333.7% |
| FY2023 | 2023-12-31 | (1.05M) | +62.8% |
| FY2022 | 2022-12-31 | (2.82M) | -50.6% |
| FY2021 | 2021-12-31 | (1.87M) | — |
Investing Cash Flow vs competitors
How SLSN compares with its peers on the latest reported figures
- SLSN's LTM Mar 2026 investing cash flow of $2.8M is the smallest of the 8 companies compared; the peer median is $14.01M.
- Its year-over-year change of -35.4% is the lowest of 7, against a peer median of +90.9%.
- Investing cash flow amounts to 4.6% of revenue for SLSN, versus a peer median of 11.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $42.52M | +177058.3% | — | 46.8% | |
| LTM Mar 2026 | $36.73M | +117.3% | +2.4% | 223.7% | |
| LTM Mar 2026 | $27.25M | +114.9% | -4.7% | 13.4% | |
| LTM Apr 2026 | $15.57M | +21.9% | — | 11.8% | |
| LTM Mar 2026 | $14.01M | +67.0% | +18.3% | 2.9% | |
AFRIForafric Global PLC | LTM Jun 2024 | $6.31M | — | — | 1.9% |
| LTM Mar 2026 | $5.67M | -7.7% | -35.1% | 1.9% | |
SLSNSolesence, Inc. Common Stock | LTM Mar 2026 | $2.8M | -35.4% | -8.8% | 4.6% |
| Peer median (excluding SLSN) | $14.01M | +90.9% | -1.1% | 11.8% | |
Competitors are the stored peer set for SLSN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 2.32M | (2.62M) | (4.39M) | 4.24M | 1.79M |
| Depreciation & Amortization | 454K | 567K | 742K | 928K | 897K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 160K | 625K | 773K | 725K | 575K |
| Change in Working Capital | (564K) | (2.79M) | 869K | (3.92M) | (11.83M) |
| Accounts Receivables | (1.01M) | (797K) | 1.06M | (1.4M) | (1.97M) |
| Inventory | (1.76M) | (2.74M) | (1.19M) | (10.24M) | 1.76M |
| Accounts Payables | 1.03M | 0 | (503K) | 2.4M | (5.38M) |
| Other Working Capital | 1.17M | 752K | 1.5M | 5.32M | (6.24M) |
| Other Non-Cash Items | (49K) | 2.57M | 0 | 0 | 0 |
| Operating Cash Flow | 2.32M | (1.65M) | (2.01M) | 1.97M | (8.57M) |
| Capital Expenditures | (1.87M) | (2.82M) | (1.05M) | (4.56M) | (2.14M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (1.87M) | (2.82M) | (1.05M) | (4.56M) | (2.14M) |
| Debt Repayment | (981K) | 5.82M | 2.52M | (5.81M) | 10.27M |
| Common Stock Issued | 0 | 182K | 0 | 0 | 323K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 234K | 0 | 73K | 2.08M | 0 |
| Financing Cash Flow | (747K) | 6M | 2.59M | 2.27M | 10.59M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (300K) | 1.53M | (464K) | (313K) | (121K) |
| Free Cash Flow | 447K | (4.47M) | (3.06M) | (2.59M) | (10.71M) |
Solesence, Inc. Common Stock
NASDAQ:SLSN
Intrinsic Alpha fair value
Locked
Current Price
$1.64
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.